Physician profile
Minjae Kim
NPI 1306361795
$3,851.71
in general payments reported to CMS, 2019-2025
20 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $606 · 2022: $602 · 2023: $1,408 · 2024: $786 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,643.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,860.35 | 2022-2025 | Proclaim, Octrode, Axium |
| Nevro Corp. | $391.15 | 2021-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $310.98 | 2021-2025 | Relistor |
| Abbvie INC. | $264.25 | 2022-2024 | |
| Globus Medical, INC. | $173.85 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $162.47 | 2022-2023 | Seglentis |
| Saluda Medical Americas, INC. | $119.00 | 2024 | Evoke |
| Boston Scientific Corporation | $101.63 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Valinor Pharma, LLC | $85.72 | 2024-2025 | Movantik |
| Allergan, INC. | $69.65 | 2021-2022 | |
| Redhill Biopharma INC. | $61.51 | 2021-2022 | |
| Si-Bone, INC. | $53.76 | 2022 | |
| Forte Bio-Pharma LLC | $39.70 | 2022-2023 | Prolate, Nalocet |
| Avanos Medical | $37.82 | 2025 | Standard Rf Disposables |
| Collegium Pharmaceutical, INC. | $23.04 | 2024 | Belbuca |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $21.61 | 2024 | Kloxxado |
| Vertex Pharmaceuticals Incorporated | $21.40 | 2025 | |
| Protega Pharmaceutials INC | $19.74 | 2024 | Roxybond |
| Virtus Pharmaceuticals LLC | $19.37 | 2021 | |
| Grt US Holding, INC. | $14.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minjae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.